One of the central impediments for
the clinical translation of
targeted nanomaterials is their extensive off-target deposition, which
can be mainly attributed to the addressed cellular surface structures
being ubiquitously present in various other regions, such as the vascular
system. This is especially important for the integrin receptor family,
which is frequently addressed with ligands such as cRGD (cyclic Arg-Gly-Asp-d-Phe-Lys). Aside from their upregulation during tumor progression,
integrins also play a prominent physiological role in endothelial
cells, to which particles are exposed immediately after injection.
However, there is a lack of understanding of how to modulate the usually
undesirable interaction of nanoparticles (NPs) with these cells, especially
under physiological conditions, that include the imminent impact of
blood flow dynamics on NP behavior. Therefore, in this study, we introduced
a steric shielding concept that is based on the addition of longer
poly(ethylene glycol) chains into the NP corona, thereby individually
camouflaging the ligand activity of cRGD-functionalized polymer NPs.
More so, we implemented a method of endothelial cell culture and particle
incubation under a constant flow, mimicking physiological conditions
(shear stress = 2–14 dyn cm–2). By controlling
the surface density (25–75%) and length (3.5 vs 5 kDa) of respective
shielding elements, in vitro NP uptake into model
endothelial cells could be precisely steered. Additionally, the NP–cell
interplay showed significant differences when examined under dynamic
conditions, confirming the need for such investigations to improve
the clinical translation of nanomaterials.